company background image
A041830 logo

InBodyLtd KOSDAQ:A041830 Stock Report

Last Price

₩23.35k

Market Cap

₩293.0b

7D

0.6%

1Y

-17.2%

Updated

08 Jan, 2025

Data

Company Financials +

A041830 Stock Overview

Provides body composition analysis solutions worldwide. More details

A041830 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

InBody Co.,Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for InBodyLtd
Historical stock prices
Current Share Price₩23,350.00
52 Week High₩30,700.00
52 Week Low₩20,700.00
Beta0.67
1 Month Change11.72%
3 Month Change-3.11%
1 Year Change-17.20%
3 Year Change0.43%
5 Year Change6.14%
Change since IPO952.27%

Recent News & Updates

There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings

Nov 12
There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings

Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital

Aug 12
Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital

Recent updates

There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings

Nov 12
There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings

Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital

Aug 12
Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital

InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Apr 12
InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Mar 25
Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Mar 08
Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

Feb 18
Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 31
How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

Jan 11
Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

Dec 17
Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 02
InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

Nov 17
Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

Shareholder Returns

A041830KR Medical EquipmentKR Market
7D0.6%8.1%4.2%
1Y-17.2%4.7%-6.0%

Return vs Industry: A041830 underperformed the KR Medical Equipment industry which returned 4.7% over the past year.

Return vs Market: A041830 underperformed the KR Market which returned -6% over the past year.

Price Volatility

Is A041830's price volatile compared to industry and market?
A041830 volatility
A041830 Average Weekly Movement4.6%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.7%
10% most volatile stocks in KR Market12.8%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A041830 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A041830's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/aKi-Chul Chawww.inbody.co.kr

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications.

InBody Co.,Ltd Fundamentals Summary

How do InBodyLtd's earnings and revenue compare to its market cap?
A041830 fundamental statistics
Market cap₩293.03b
Earnings (TTM)₩31.81b
Revenue (TTM)₩191.30b

9.4x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A041830 income statement (TTM)
Revenue₩191.30b
Cost of Revenue₩42.99b
Gross Profit₩148.31b
Other Expenses₩116.51b
Earnings₩31.81b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.48k
Gross Margin77.53%
Net Profit Margin16.63%
Debt/Equity Ratio0%

How did A041830 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

14%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 16:41
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InBody Co.,Ltd is covered by 17 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kathy ParkCGS International
null nullDBS Bank Ltd
Jaesong WooHaitong International Research Limited